Primary hyperparathyroidism and celiac disease: A population-based cohort study

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 3, 2012, Pages 897-904

  Ludvigsson, Jonas F ^a,b   Kam̈pe, Olle ^c   Lebwohl, Benjamin ^d   Green, Peter H R ^d   Silverberg, Shonni J ^d   Ekbom, Anders ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; AMBULATORY SURGERY; ARTICLE; CELIAC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HOSPITAL PATIENT; HUMAN; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OUTPATIENT CARE; POPULATION RESEARCH; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; CELIAC DISEASE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; RISK; RISK FACTORS; SWEDEN;

EID: 84858062265     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2639     Document Type: Article

References (34)

1. Bilezikian JP, Silverberg SJ 2004 Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl J Med 350:1746-1751 (Pubitemid 38501143)
2. Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, Rao DS, Rubin MR, Goltzman D, Silverberg SJ, Marx SJ, Peacock M, Mosekilde L, Bouillon R, Lewiecki EM 2009 Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:340-350
3. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR 2009 Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:351-365
4. Ludvigsson JF, Green PH 2011 Clinical management of coeliac disease. J Intern Med 269:560-571
5. Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, Macneil J, Mack D, Patel D, Moher D 2005 The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 128:S57-S67 (Pubitemid 40460823)
6. Collin P, Reunala T, Pukkala E, Laippala P, Keyriläinen O, Pasternack A 1994 Coeliac disease-associated disorders and survival. Gut 35:1215-1218
7. Elfström P, Montgomery SM, Kämpe O, Ekbom A, Ludvigsson JF 2008 Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 93:3915-3921
8. Maida MJ, Praveen E, Crimmins SR, Swift GL 2006 Coeliac disease and primary hyperparathyroidism: an association? Postgrad Med J 82:833-835 (Pubitemid 46101934)
9. Alzahrani AS, Al Sheef M 2008 Severe primary hyperparathyroidism masked by asymptomatic celiac disease. Endocr Pract 14:347-350
10. Wu SC, Caravita S, Secchi MB 13 February 2011 Hyperparathyroidism in celiac disease: always secondary? Intern Emerg Med doi: 10.1007/s11739-011-0533- 7
11. Marsh MN 1992 Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102:330-354
12. Ludvigsson JF, Brandt L, Montgomery SM, Granath F, Ekbom A 2009 Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterol 9:19
13. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A 2009 The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24:659-667
14. Ludvigsson JF, Montgomery SM, Ekbom A, Brandt L, Granath F 2009 Small-intestinal histopathology and mortality risk in celiac disease. JAMA 302:1171-1178
15. Johannesson I 2002 The total population register of statistics Sweden. New possibilities and better quality.Örebro, Sweden: Statistics Sweden
16. Welander A, Prütz KG, Fored M, Ludvigsson JF 2012 Increased risk of end-stage renal disease in individuals with coeliac disease. Gut 61:64-68
17. Fraser WD 2009 Hyperparathyroidism. Lancet 374:145-158
18. Sharretts JM, Simonds WF 2010 Clinical and molecular genetics of parathyroid neoplasms. Best Pract Res Clin Endocrinol Metab 24: 491-502
19. Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, Eisenbarth GS 1999 One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 13:143-148 (Pubitemid 29367018)
20. Yu N, Donnan PT, Leese GP 2011 A record linkage study of outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) 75:169-176
21. Gul K, Ozdemir D, Korukluoglu B, Ersoy PE, Aydin R, Ugras SN, Ersoy R, Cakir B 2010 Preoperative and postoperative evaluation of thyroid disease in patients undergoing surgical treatment of primary hyperparathyroidism. Endocr Pract 16:7-13
22. Taylor WH, Khaleeli AA 1997 Prevalence of primary hyperparathyroidism in patients with diabetes mellitus. Diabet Med 14:386-389 (Pubitemid 27248020)
23. Rödström K, Bengtsson C, Milsom I, Lissner L, Sundh V, Bjoürkelund C 2003 Evidence for a secular trend in menopausal age: a population study of women in Gothenburg. Menopause 10:538-543 (Pubitemid 40228149)
24. Pais WP, Duerksen DR, Pettigrew NM, Bernstein CN 2008 How many duodenal biopsy specimens are required to make a diagnosis of celiac disease? Gastrointest Endosc 67:1082-1087
25. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO 2011 External review and validation of the Swedish national inpatient register. BMC Public Health 11:450
26. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton 3rd LJ 2006 Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 21:171-177 (Pubitemid 43023239)
27. Stenström G, Heedman PA 1974 Clinical findings in patients with hypercalcaemia. A final investigation based on biochemical screening. Acta Med Scand 195:473-477
28. Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R 2005 Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 165:393-399 (Pubitemid 40280193)
29. Ludvigsson JF, Michaelsson K, Ekbom A, Montgomery SM 2007 Coeliac disease and the risk of fractures-a general populationbased cohort study. Aliment Pharmacol Ther 25:273-285 (Pubitemid 46115397)
30. Emilsson L, Smith JG, West J, Melander O, Ludvigsson JF 2011 Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study. Eur Heart J 32:2430-2437
31. Ludvigsson JF, Sanders DS, Maeurer M, Jonsson J, Grunewald J, Wahlström J 2011 Risk of tuberculosis in a large sample of patients with coeliac disease-a nationwide cohort study. Aliment Pharmacol Ther 33:689-696
32. Elfström P, Granath F, Ekström Smedby K, Montgomery SM, Askling J, Ekbom A, Ludvigsson JF 2011 Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst 103:436-444
33. Elfström P, Granath F, Ye W, Ludvigsson JF 2012 Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol 10: 30-36
34. Selby PL, Davies M, Adams JE, Mawer EB 1999 Bone loss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res 14:652-657 (Pubitemid 29153400)